MS
OM icon

Maven Securities’s Outset Medical OM Stock Holding History

Maven Securities’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,331
Closed -$1.12M – 1242
2021
Q1 		$1.12M Sell
1,331
-10,318
-89% -$7.96M 0.05% 370
2020
Q4 		$10.4M Buy
11,649
+9,659
+485% +$7.44M 1.02% 15
2020
Q3 		$1.48M Buy
+1,990
New +$1.63M 0.12% 173

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Maven Securities's OM Position: Q2 2021 in Review

Maven Securities sold out of Outset Medical (OM) in Q2 2021, closing a stake of 1,331 shares — an estimated $1.12M sold.

Maven Securities first reported a position in OM in Q3 2020 and held it in 3 quarters. The position peaked at $10.4M in Q4 2020. 129 funds tracked by Wall St. Rank hold OM as of Q2 2021.

  • Maven Securities reported no remaining Outset Medical position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 1,331 Outset Medical shares in Q2 2021, an estimated $1.12M.
  • Maven Securities first reported a position in Outset Medical in Q3 2020 and held it in 3 quarters.
  • Maven Securities's Outset Medical position peaked at $10.4M in Q4 2020.
  • 129 funds tracked by Wall St. Rank held Outset Medical as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.